儿童过敏性哮喘尘螨过敏原特异性免疫治疗循证指南(患者版)

Evidence-based guideline for dust mite allergen immunotherapy in children with allergic asthma(Patient Version)

儿童过敏性哮喘(AA)的患病率呈现不断增长的趋势,尘螨是最常见的吸入性过敏原,尘螨过敏原特异性免疫治疗(AIT)是过敏性疾病的对因治疗。当前大众对AIT认识不足,国内外缺乏针对儿童及家长的关于AA尘螨AIT的指南。为此,基于国内外循证医学证据,结合专家的经验和患儿及家长的需求,组织专家组制定本指南,就尘螨AIT的适用人群、治疗时机、治疗途径、疗效判断、不良反应、联合用药等方面进行详细阐述,旨在提高AA患儿及家长对尘螨AIT的认识及依从性,实现对AA患儿"四位一体"的综合管理。

The prevalence of allergic asthma(AA)in children is increasing trend.Dust mite is the most common inhaled allergen.Dust mite allergen immunotherapy(AIT)is the cause treatment of allergic diseases.However,the public′s understanding of AIT is insufficient and there is a lack of specific guideline of dust mite AIT for children with AA and their parents.Therefore,based on evidence-based medicine at home and abroad,combined with the experience of experts and the needs of children and parents,this guideline was formulated,which includes suitable crowd,treatment time,treatment approaches,curative effect judgment,adverse reactions and drug combination of dust mite AIT.This guideline aims to improve the awareness and compliance of dust mite AIT in children with AA and their parents,and achieve comprehensive management of AA in children with a"four in one"manner.